5.03
-1.52 (-23.21%)
| Previous Close | 6.55 |
| Open | 5.40 |
| Volume | 1,901,110 |
| Avg. Volume (3M) | 4,008,450 |
| Market Cap | 9,185,042 |
| Price / Sales | 302.57 |
| Price / Book | 0.770 |
| 52 Weeks Range | |
| Earnings Date | 12 Mar 2026 |
| Operating Margin (TTM) | -173,463.83% |
| Diluted EPS (TTM) | -4.34 |
| Quarterly Revenue Growth (YOY) | -94.10% |
| Total Debt/Equity (MRQ) | 7.00% |
| Current Ratio (MRQ) | 19.49 |
| Operating Cash Flow (TTM) | -5.16 M |
| Levered Free Cash Flow (TTM) | -3.50 M |
| Return on Assets (TTM) | -43.94% |
| Return on Equity (TTM) | -81.24% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Bullish | Mixed |
| Biotechnology (Global) | Bullish | Mixed | |
| Stock | Cardio Diagnostics Holdings Inc | Mixed | Mixed |
AIStockmoo Score
| Analyst Consensus | 2.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 2.0 |
| Average | 1.13 |
|
Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenetic EngineTM for cardiovascular disease to become the leading medical technology company for enabling improved prevention, early detection, and assistance in the treatment of cardiovascular disease. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Growth |
| % Held by Insiders | 7.55% |
| % Held by Institutions | 4.86% |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 07 Jan 2026 | Announcement | Cardio Diagnostics, Aimil Ltd. and Dr. Lal PathLabs Limited Partner to Launch the PrecisionCHD™ Test in India |
| 06 Jan 2026 | Announcement | Cardio Diagnostics Holdings, Inc. and Southdale YMCA Announce New Heart Health Partnership to Serve the Edina, Minnesota Community |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |